Fund HoldingsGILEAD SCIENCES, INC.

Total Portfolio Value
$1.28B
Total Bought
$0
Total Sold
$6.24M
Net Transaction
-$6.24M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
GALAPAGOS NV(LKFT)16,707,47716,707,4770419,394467,64236.53%+48,248
ASSEMBLY BIOSCIENCES INC2,209,4712,209,471021,12340,0363.13%+18,913
TANGO THERAPEUTICS INC(TNGX)4,854,4434,854,44306,65124,8551.94%+18,204
ARCUS BIOSCIENCES INC(RCUS)31,424,76031,424,7600246,684255,79819.98%+9,113
MERUS N V452,527452,527019,04723,8031.86%+4,756
KYVERNA THERAPEUTICS INC4,126,1194,126,11907,96312,6670.99%+4,704
ARCELLX INC
COMMON STOCK
6,720,8036,720,8030440,885442,56534.57%+1,680
HOOKIPA PHARMA INC1,875,9451,875,94502,0262,3540.18%+328
LEAP THERAPEUTICS INC5,319,1485,319,14801,6231,5790.12%-44
BARINTHUS BIOTHERAPEUTICS PL369,85599,478-270,377360930.01%-267
ALLOGENE THERAPEUTICS INC1,156,6891,156,68901,6891,3070.10%-382
XILIO THERAPEUTICS INC9,105,4519,105,45106,5966,1910.48%-405
IKENA ONCOLOGY INC1,159,145348,534-810,6111,4844670.04%-1,017
KALARIS THERAPEUTICS INC723,273317,789-405,4845,8088480.07%-4,959
Page 1 of 1